European journal of internal medicine
Endothelin-1 as dual marker for renal function decline and associated cardiovascular complications in patients with chronic kidney disease.
Laura González-Rodríguez, Manuel Martí-Antonio, Sonia Mota-Zamorano, Celia Chicharro, Bárbara Cancho, Enrique Luna, Álvaro Álvarez, Zoraida Verde, Fernando Bandrés, Nicolás R Robles, Guillermo Gervasini
Published: 202510.1016/j.ejim.2025.106542
Abstract
BACKGROUND: Cardiovascular (CV) complications are the leading cause of death in patients with chronic kidney disease (CKD). Endothelin-1 (ET-1), a potent vasoconstrictor involved in both renal and vascular dysfunction, may represent a promising bioma…
Preview only. Read the full abstract at the source